Home > Name List By 2 > 2-[[3-methyl-4-(2,2, 2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

CAS No 103577-45-3 , 2-[[3-methyl-4-(2,2,
2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

  • Name: 2-[[3-methyl-4-(2,2,
    2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
  • Synonyms: Lanzor; Limpidex; Monolitum;2-[[3-methyl-4-(2,2,
    2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole; Agopton; Opiren; Lanzopral; Prevacid;Bamalite; Ogastro;
  • CAS Registry Number:
  • Flash Point: 289.9 ºC
  • Boiling Point: 555.8ºC at 760 mmHg
  • Density: 1.5 g/cm3
  • Refractive index: 1.591
  • Safety Statements: R36/37/38
  • Hazard Symbols: Xi: Irritant;
  • Flash Point: 289.9 ºC
  • Molecular Weight: 369.36147
  • InchiKey: MJIHNNLFOKEZEW-UHFFFAOYSA-N
  • InChI: InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,
    18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
  • Risk Statements: S26;S36
  • Molecular Formula: C16H14F3N3O2S
  • Molecular Structure:CAS No:103577-45-3 2-[[3-methyl-4-(2,2,<br />2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

Related products

Search by region :

Select to

103577-45-3 LANSOPRAZOLE

  • United States Haorui Pharma-Chem Inc. [Manufacturer]
  • Tel: 732-906-7666
  • Fax: 732-906-1522
  • Address: Haorui Pharma-Chem Inc.
    100 menlo Park Drive
    Suite 316
    Edison, NJ 08837 null,nullUnited States
Contact Supplier

103577-45-3 lansoprazole

Contact Supplier

103577-45-3 lansoprazole

Contact Supplier

103577-45-3 Lansoprazole

  • India Triveni Chemicals null
  • Tel: +91-(260)-2400022, 3258683
  • Fax: +91-(260)-2400022/3264008
  • Address: 135, Pancharatna, Char Rasta, G.I.D.C., Vapi, Gujarat 396 195, null,nullIndia
Contact Supplier

103577-45-3 lansoprazole

  • China Boronsyn Co.,Ltd [Manufacturer]
  • Tel: +86-21-58407925
  • Fax: +86-21-58408291
  • Address: 1213 JunMin Road,Pudong,China null,nullChina
Contact Supplier

103577-45-3 lansoprazole

  • China YiPeng Chemical [Manufacturers]
  • Tel: 571 85376369
  • Fax: 571 88233092
  • Address: Building 4,High-tech Industrial Park,No. 588 Feijiatang Road,Xiacheng District, Hangzhou, China null,ZheJiangChina
Contact Supplier

103577-45-3 2-[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL]METHYLSULFINYL]-1H-BENZOIMIDAZOLE LANSOPRAZOLE

Contact Supplier

103577-45-3 Lansoprazole

  • Lansoprazole Rank: Pharmaceutical Raw Material Cas No. 103577-45-3 Molecular formula: C16H14F3N3O2S Molecular weight: 369.37 Appearance: White rime dust Melting point: 170.0-170.5
  • China Wuhan Yuancheng Gongchuang Technology Co., Ltd. [Manufacturer]
  • Tel: 86-27-88310829
  • Fax: 86-27-88064757
  • Address: 496#, zhongshan road, wuhan wuhan,nullChina
Contact Supplier

103577-45-3 Lansoprazole

Contact Supplier

103577-45-3 Lansoprazole

  • China Kouting Chemical Co.,Ltd [Importer/Exporter]
  • Tel: +86-(21)-58116473
  • Fax: +86-(21)-61094103
  • Address: Hunan Road, Pudong New District, Shanghai, Shanghai 201318, shanghai,shanghaiChina
Contact Supplier

Select to

5/14
Previous 1 2 3 4 5 6 7 8 9 10 Next
References of 2-[[3-methyl-4-(2,2,
2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
Title: Lansoprazole
CAS Registry Number: 103577-45-3
CAS Name: 2-[[[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
Synonyms: 2-(2-benzimidazolylsulfinylmethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
Manufacturers' Codes: A-65006; AG-1749
Trademarks: Agopton (Takeda); Lansox (Takeda); Lanzor (Aventis); Limpidex (Sigma-Tau); Ogast (Takeda); Prevacid (TAP); Takepron (Takeda); Zoton (Wyeth)
Molecular Formula: C16H14F3N3O2S
Molecular Weight: 369.36
Percent Composition: C 52.03%, H 3.82%, F 15.43%, N 11.38%, O 8.66%, S 8.68%
Literature References: Gastric proton-pump inhibitor. Prepn: A. Nohara, Y. Maki, EP 174726; eidem, US 4628098 (both 1986 to Takeda). HPLC determn in plasma: T. Uno et al., J. Chromatogr. B 816, 309 (2005). Pharmacology: H. Satoh et al., J. Pharmacol. Exp. Ther. 248, 806 (1989). Mechanism of action study: H. Nagaya et al., ibid. 252, 1289 (1990). Clinical pharmacology and effect on human gastric acid secretion: P. Müller et al., Aliment. Pharmacol. Ther. 3, 193 (1989). Review of pharmacology and clinical experience: H. D. Langtry, M. I. Wilde, Drugs 54, 473-500 (1997). Comparative clinical trial with esomeprazole in erosive esophagitis: C. W. Howden et al., Clin. Drug Invest. 22, 99 (2002).
Properties: mp 178-182° (dec).
Melting point: mp 178-182° (dec)
Therap-Cat: Antiulcerative.
Keywords: Antiulcerative; Gastric Proton Pump Inhibitor.